Oberland Capital is a private investment firm focused exclusively on investing in the global healthcare industry. Our innovative financing solutions are structured to meet the needs of a wide-range of healthcare companies and royalty holders.
The firm was founded by Managing Partners Jean-Pierre Naegeli and Andrew Rubinstein, who have more than 20 years of combined experience in traditional and structured healthcare royalty investing and over 35 years of relevant healthcare-related structuring, licensing and operating experience.
The broader investment team has over 85 years of relevant healthcare and finance experience. The team possesses significant financial and operational expertise built throughout long tenures in the healthcare industry in a diverse array of senior management, principal investing, investment banking, and consulting roles. Our knowledge base spans the pharmaceutical, biotechnology, medical device, and diagnostic sectors, and numerous therapeutic categories. The team’s extensive experience in the United States, Europe and other territories allows us to effectively source, diligence, structure, and execute transactions across the globe.